Skip to main content
Quest Diagnostics

Clinical Performance Evaluation of a Multiplex PCR Panel for Central Nervous System Infections

ASM 2025

American Society for Microbiology

Los Angeles, CA, June 19-23, 2025

Poster presentation: Clinical Performance Evaluation of a Multiplex PCR Panel for Central Nervous System Infections

Authors: Farnsworth C, Ren P, Gonzalez Lopez J, Bialas J, Humphries R, Davis T, Simner PJ, Ledeboer N, Dunn J, Dhiman N, Caspar Y, Wolk D, Rey M, Juanola-Falgarona M, Fern S, Johnson S, Hansen G, and Pancholi P

Medical Specialty: Infectious disease, Neurology

Related content

Conference Presentation
Multiplex Detection and Quantification of Neurological Disease-Associated Repeat Expansions Using the PacBio Sequel II Platform
Conference Presentation
What’s New with Multiplex Testing: Panels, Targets, and Reimbursement Updates
Conference Presentation
Diagnostic stewardship in the era of multiplex molecular panels

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.